CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine

Abstract

With the discovery of CRISPR-Cas9, drug development and precision medicine have undergone a major change. This review article looks at the new ways that CRISPR-based therapies are being used and how they are changing the way medicine is done. CRISPR technology's ability to precisely and flexibly edit genes has opened up new ways to find, validate, and develop drug targets. Also, it has made way for personalized gene therapies, precise gene editing, and advanced screening techniques, all of which hold great promise for treating a wide range of diseases. In this article, we look at the latest research and clinical trials that show how CRISPR could be used to treat genetic diseases, cancer, infectious diseases, and other hard-to-treat conditions. However, ethical issues and problems with regulations are also discussed in relation to CRISPR-based therapies, which shows how important it is to use them safely and responsibly. As CRISPR continues to change how drugs are made and used, this review shines a light on the amazing things that have been done and what the future might hold in this rapidly changing field.

CRISPR/Cas9 gene editing: a novel strategy for fighting drug resistance in respiratory disorders

“…CRISPR/Cas9 technology has rapidly advanced since its initial discovery, leading to several modifications and improvements that have expanded its therapeutic utility [ 61 ] (Table 1 ). One of the key advancements and new modifications in CRISPR/Cas9 technology is base editing.…”